FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing…
The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing…